Subscribe
Consulting
Services
Market Opportunity & Competitive Analysis
Primary Research
M&A Diligence
Go-To-Market Strategy & Business Cases
Business Development & Licensing
Pricing Strategy & Willingness to Pay
Portfolio Strategy & Prioritization
Regulatory Strategy
Area of Expertise
Cell & Gene Therapy
Oncology
Biotech
Investors
Contract Services
Diagnostics
Ventures
About Kineticos Ventures
Portfolio Companies
Antimicrobial Resistance (AMR)
Kineticos Investment Focus
Senior Team
News
Investor Portal
Knowledge Center
Videos
Podcasts
How To Insights
Whitepapers
CEO Biopharma Confidence Index
Case Studies
About Us
The Kineticos Difference
Senior Team
Our Customers
What Our Customers Say
Careers
News
Contact
Consulting
Services
Market Opportunity & Competitive Analysis
Primary Research
M&A Diligence
Go-To-Market Strategy & Business Cases
Business Development & Licensing
Pricing Strategy & Willingness to Pay
Portfolio Strategy & Prioritization
Regulatory Strategy
Area of Expertise
Cell & Gene Therapy
Oncology
Biotech
Investors
Contract Services
Diagnostics
Ventures
About Kineticos Ventures
Portfolio Companies
Antimicrobial Resistance (AMR)
Kineticos Investment Focus
Senior Team
News
Investor Portal
Knowledge Center
Videos
Podcasts
How To Insights
Whitepapers
CEO Biopharma Confidence Index
Case Studies
About Us
The Kineticos Difference
Senior Team
Our Customers
What Our Customers Say
Careers
News
Contact
August 26, 2018
A Primer on Immuno-Oncology: Part 1
Cell & Gene Therapy
Oncology
In the first part of the Immuno-Oncology Primer, we will provide an overview of anti-cancer vaccines and cytokines before delving into a discussion of immune checkpoint inhibitors. (2018)
Download PDF
Back to Index